Fig 5.tif (986.37 kB)
Single-viral dosing scheme under scenario 2.
figure
posted on 2017-09-21, 17:39 authored by Khaphetsi Joseph Mahasa, Amina Eladdadi, Lisette de Pillis, Rachid OuifkiPlots of individual susceptible normal and tumor cell populations when the single dose of V = 109 pfu is administered at three different time points when . Fig 5(a) shows a reduction and rapid self-renewing of the susceptible normal cell population during an oncolytic virotherapy. Fig 5(b) shows the reduction of uninfected tumor cell population under the single-viral dose scheme.